# BELITE BIO INC (BLTE)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/BLTE/

- Reporting holders: 2
- Reported value: $307.5K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $300.8K | 1,771 | 0.0% | 12 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $6.8K | 40 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 2 | $307.5K |
| Q2 2026 | 82 | $1.5B |
| Q1 2026 | 75 | $1.4B |
| Q4 2025 | 69 | $1.2B |
| Q3 2025 | 34 | $170.1M |
| Q2 2025 | 18 | $4.5M |
| Q1 2025 | 18 | $9.9M |
| Q4 2024 | 21 | $17.8M |
| Q3 2024 | 15 | $4.0M |
| Q2 2024 | 11 | $8.5M |
| Q1 2024 | 11 | $2.7M |
| Q4 2023 | 17 | $8.8M |